Treatment strategies for the right heart in pulmonary hypertension

Cardiovasc Res. 2017 Oct 1;113(12):1465-1473. doi: 10.1093/cvr/cvx148.

Abstract

The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus on ways to reduce wall stress since this is the main determinant of changes to the ventricle. Secondly, we discuss treatment strategies targeting the detrimental consequences of increased RV wall stress. To reduce wall stress, afterload reduction is the essential. Additionally, preload to the ventricle can be reduced by diuretics, by atrial septostomy, and potentially by mechanical ventricular support. Secondary to ventricular wall stress, left-to-right asynchrony, altered myocardial energy metabolism, and neurohumoral activation will occur. These may be targeted by optimising RV contraction with pacing, by iron supplement, by angiogenesis and improving mitochondrial function, and by neurohumoral modulation, respectively. We conclude that several treatment strategies for the right heart are available; however, evidence is still limited and further research is needed before clinical application can be recommended.

Keywords: Beta-blockade; Cardiac resynchronisation; Diuretics; Mitochondrial function; Ventricular-assist device.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Animals
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / metabolism
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / therapy*
  • Arterial Pressure / drug effects*
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy*
  • Diuretics / therapeutic use
  • Energy Metabolism / drug effects
  • Heart-Assist Devices
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / metabolism
  • Hypertension, Pulmonary / physiopathology
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / metabolism
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / physiopathology
  • Treatment Outcome
  • Ventricular Dysfunction, Right / etiology
  • Ventricular Dysfunction, Right / metabolism
  • Ventricular Dysfunction, Right / physiopathology
  • Ventricular Dysfunction, Right / therapy*
  • Ventricular Function, Right / drug effects*

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Diuretics